Advertisement
Advertisement
U.S. Markets close in 2 hrs 29 mins
Advertisement
Advertisement
Advertisement
Advertisement

IGM Biosciences, Inc. (IGMS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
24.35-1.05 (-4.11%)
As of 01:29PM EST. Market open.
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 2/3/2023
Current
Market Cap (intraday)
N/A
Enterprise Value
N/A
Trailing P/E
N/A
Forward P/E
N/A
PEG Ratio (5 yr expected)
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue
N/A
Enterprise Value/EBITDA
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) -0.42
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 335.98
52 Week Low 312.67
50-Day Moving Average 320.47
200-Day Moving Average 319.50

Share Statistics

Avg Vol (3 month) 3245.4k
Avg Vol (10 day) 3129.93k
Shares Outstanding 526.03M
Implied Shares Outstanding 6N/A
Float 811.32M
% Held by Insiders 138.62%
% Held by Institutions 162.98%
Shares Short (Oct 13, 2022) 43.45M
Short Ratio (Oct 13, 2022) 417.15
Short % of Float (Oct 13, 2022) 430.01%
Short % of Shares Outstanding (Oct 13, 2022) 48.08%
Shares Short (prior month Sep 14, 2022) 43.22M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Jun 29, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-56,300.27%

Management Effectiveness

Return on Assets (ttm)-27.61%
Return on Equity (ttm)-58.83%

Income Statement

Revenue (ttm)366k
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -200.99M
Net Income Avi to Common (ttm)-205.3M
Diluted EPS (ttm)-4.23
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)513.2M
Total Cash Per Share (mrq)12.03
Total Debt (mrq)29.12M
Total Debt/Equity (mrq)7.76
Current Ratio (mrq)14.57
Book Value Per Share (mrq)8.83

Cash Flow Statement

Operating Cash Flow (ttm)3.35M
Levered Free Cash Flow (ttm)-78.92M
Advertisement
Advertisement